Idelvion has albutrepenonacog alfa, which is an active substance that is indicated for the prevention and treatment of bleeding in people with hemophilia B, which is a hereditary hemorrhagic disease caused by a deficiency of a coagulation protein, called factor IX .
This medicine, in addition to being used in the prevention and treatment of hemophilia B, can also be used to control and prevent bleeding in surgical settings.
Idelvion is in the form of an injectable and can only be obtained by prescription.
How to use
Idelvion should be given into the vein by a health professional, and the dose and frequency of injections depend on the person's age, body weight and health status, the stage of the disease and the administration, ie if it is to prevent or treat hemophilia or to control bleeding during surgery.
What is the mechanism of action
Albutrepenonacog alfa acts in the body in the same way as human factor IX, which is a coagulation factor.
Because hemophilia B is a disease caused by factor IX deficiency, this remedy restores missing factor IX, thereby helping the blood to coagulate and allowing temporary bleeding control. Clarify your doubts about Hemophilia.
Possible side effects
The most common side effects that can occur with Idelvion are swelling, burning and stinging at the injection site, shivering, hot flashes, skin rash, itching, headache, hives, low blood pressure, lethargy, nausea and vomiting, agitation, increased heartbeat, chest tightness, and wheezing.
Who should not use
This medicine should not be used in people who are hypersensitive to any of the ingredients present in the formula or who are allergic to hamster proteins.
Pregnant women and women who are breast-feeding should not use Idelvion unless recommended by their doctor.
